1 / 7

Study on ISIS 301012 Effects on Lipid Levels

This study by John J.P. Kastelein et al. in Circulation 2006 delves into the dosing, follow-up schedule, demographics, and adverse events related to ISIS 301012. It analyzes the dose-dependent impact of ISIS 301012 on apoB and LDL cholesterol levels.

sigourney-wyatt
Download Presentation

Study on ISIS 301012 Effects on Lipid Levels

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Flow of study participants John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

  2. Dosing and follow-up schedule John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

  3. Subject Demographics and Baseline Lipid Characteristics* John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

  4. Adverse Events Considered Related to Study Medication by Dosage John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

  5. Dose-dependent effect of ISIS 301012 on apoB levels John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

  6. Dose-dependent effect of ISIS 301012 on LDL cholesterol levels John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

  7. ApoB and LDL-C Levels by Mean Percent Change Relative to Baseline* John J.P. Kastelein, et al. Circulation 2006;114:1729-1735

More Related